Citadel Securities maintains an 'Add' on Shire plc (SHPGY); Firazyr Approval Likely, but Market Opportunity Limited
Tweet
Share
E-mailGet Alerts SHPGY Hot Sheet
Price: $85.67 -0.2%
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Citadel Securities maintains an 'Add' on Shire plc (NASDAQ: SHPGY), PT $97.
Citadel analyst said, "We forsee no impact to our Cinryze revenue estimates assuming approval of SHPGY's Firazyr for the treatment of acute hereditary angioedema (HAE). Importantly, we believe the potential for off-label use of Firazyr in the prophylactic setting is almost nonexistent. As such, we maintain and reiterate our 2011 and 2012 Cinryze revenue estimates of $255.9MM and $365.0MM, respectively, driven by growth in the prophylaxis HAE market. Notably, we believe the potential approval and commercialization of Firazyr will mirror that of Dyax's Kalbitor and CSL's Berinert, which have had no measurable effect on Cinryze revenues.
For more ratings news on Shire plc click here and for the rating history of Shire plc click here.
Shares of Shire plc closed at $89.65 yesterday.
Citadel analyst said, "We forsee no impact to our Cinryze revenue estimates assuming approval of SHPGY's Firazyr for the treatment of acute hereditary angioedema (HAE). Importantly, we believe the potential for off-label use of Firazyr in the prophylactic setting is almost nonexistent. As such, we maintain and reiterate our 2011 and 2012 Cinryze revenue estimates of $255.9MM and $365.0MM, respectively, driven by growth in the prophylaxis HAE market. Notably, we believe the potential approval and commercialization of Firazyr will mirror that of Dyax's Kalbitor and CSL's Berinert, which have had no measurable effect on Cinryze revenues.
For more ratings news on Shire plc click here and for the rating history of Shire plc click here.
Shares of Shire plc closed at $89.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Deere (DE) PT Raised to $585 at JPMorgan
- Benchmark Reiterates Buy Rating on NVIDIA (NVDA), Updates Estimates
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
